REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,615,943 | -54.2% | 838,356 | +1.0% | 0.00% | -50.0% |
| Q2 2023 | $21,001,580 | -19.1% | 829,774 | +2.9% | 0.00% | -20.0% |
| Q1 2023 | $25,964,480 | +77.3% | 806,100 | +1.6% | 0.01% | +66.7% |
| Q4 2022 | $14,646,773 | -24.2% | 793,433 | +10.9% | 0.00% | -25.0% |
| Q3 2022 | $19,323,000 | +106.2% | 715,649 | +5.5% | 0.00% | +100.0% |
| Q2 2022 | $9,373,000 | -32.0% | 678,300 | -4.0% | 0.00% | 0.0% |
| Q1 2022 | $13,778,000 | +15.6% | 706,616 | -3.3% | 0.00% | 0.0% |
| Q4 2021 | $11,922,000 | -42.0% | 730,557 | -1.0% | 0.00% | -50.0% |
| Q3 2021 | $20,562,000 | -7.7% | 738,082 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $22,284,000 | +10.4% | 751,852 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $20,176,000 | -6.8% | 721,863 | -5.5% | 0.00% | 0.0% |
| Q4 2020 | $21,642,000 | +9.4% | 763,624 | -3.0% | 0.00% | 0.0% |
| Q3 2020 | $19,784,000 | +9.7% | 786,928 | +6.6% | 0.00% | 0.0% |
| Q2 2020 | $18,033,000 | +84.2% | 738,465 | +11.7% | 0.00% | +33.3% |
| Q1 2020 | $9,788,000 | +2.7% | 661,392 | +12.6% | 0.00% | +50.0% |
| Q4 2019 | $9,534,000 | +30.3% | 587,424 | +4.4% | 0.00% | 0.0% |
| Q3 2019 | $7,318,000 | +11.6% | 562,930 | +11.4% | 0.00% | 0.0% |
| Q2 2019 | $6,556,000 | -16.6% | 505,445 | +1.3% | 0.00% | 0.0% |
| Q1 2019 | $7,864,000 | -8.8% | 498,934 | +16.5% | 0.00% | 0.0% |
| Q4 2018 | $8,622,000 | -20.9% | 428,350 | -2.4% | 0.00% | -33.3% |
| Q3 2018 | $10,906,000 | -4.5% | 438,869 | +5.5% | 0.00% | 0.0% |
| Q2 2018 | $11,415,000 | +9.2% | 415,856 | +22.5% | 0.00% | 0.0% |
| Q1 2018 | $10,455,000 | -3.0% | 339,450 | +12.6% | 0.00% | 0.0% |
| Q4 2017 | $10,774,000 | +34.4% | 301,405 | +3.6% | 0.00% | +50.0% |
| Q3 2017 | $8,015,000 | -4.8% | 290,950 | -8.8% | 0.00% | 0.0% |
| Q2 2017 | $8,418,000 | +52.2% | 318,877 | +19.9% | 0.00% | 0.0% |
| Q1 2017 | $5,532,000 | +2.7% | 265,937 | +2.2% | 0.00% | 0.0% |
| Q4 2016 | $5,389,000 | +32.1% | 260,314 | +3.5% | 0.00% | +100.0% |
| Q3 2016 | $4,078,000 | +29.4% | 251,538 | +8.5% | 0.00% | 0.0% |
| Q2 2016 | $3,152,000 | -16.0% | 231,794 | +7.9% | 0.00% | 0.0% |
| Q1 2016 | $3,751,000 | -48.2% | 214,855 | +1.4% | 0.00% | -50.0% |
| Q4 2015 | $7,240,000 | +37.2% | 211,966 | +19.5% | 0.00% | 0.0% |
| Q3 2015 | $5,277,000 | +55.0% | 177,308 | +66.6% | 0.00% | +100.0% |
| Q2 2015 | $3,404,000 | +61.5% | 106,423 | +4.7% | 0.00% | 0.0% |
| Q1 2015 | $2,108,000 | +34.6% | 101,676 | +10.0% | 0.00% | – |
| Q4 2014 | $1,566,000 | -10.9% | 92,450 | +1.6% | 0.00% | -100.0% |
| Q3 2014 | $1,758,000 | -30.7% | 90,979 | +22.0% | 0.00% | 0.0% |
| Q2 2014 | $2,535,000 | +181.4% | 74,564 | +160.8% | 0.00% | – |
| Q1 2014 | $901,000 | – | 28,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |